Capoor Malini R, Bhowmik Kumar Tapas
Department of Microbiology, VMMC and Safdarjung Hospital, New Delhi, India.
Department of Radiotherapy, Biomedical Waste Unit, VMMC and Safdarjung Hospital, New Delhi, India.
Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):190-197. doi: 10.4103/ijmpo.ijmpo_174_16.
This article deals with practices related to cytotoxic drug dispersal, cytotoxic safety, and cytotoxic waste management and attempts at India-specific guidelines for their dispersal and disposal. The articles related to cytotoxic drug dispersal, cytotoxic safety, and cytotoxic waste management were reviewed from PubMed and their applicability in Indian health-care facilities (HCFs) was also reviewed. All HCFs dealing with cytotoxic drugs should consider cytotoxic policy, patient safety and health-care worker safety, and environmental monitoring program as per the available international guidelines customized as per Indian conditions. Utmost care in handling cytotoxic waste is quintessential. The formation of India-specific cytotoxic guidelines requires the inputs from all stakeholders. Cytotoxic waste, cytotoxic safety, and cytotoxic waste management should be the subject of a national strategy with an infrastructure, cradle-to-grave legislation, competent regulatory authority, and trained personnel.
本文论述了与细胞毒性药物分发、细胞毒性安全及细胞毒性废物管理相关的实践，并尝试制定针对印度的细胞毒性药物分发与处置指南。从PubMed数据库中检索了与细胞毒性药物分发、细胞毒性安全及细胞毒性废物管理相关的文章，并对其在印度医疗机构中的适用性进行了评估。所有处理细胞毒性药物的医疗机构都应根据印度国情定制的现有国际指南，考虑细胞毒性政策、患者安全、医护人员安全以及环境监测计划。在处理细胞毒性废物时必须格外小心。制定印度特有的细胞毒性指南需要所有利益相关者的投入。细胞毒性废物、细胞毒性安全及细胞毒性废物管理应成为一项国家战略的主题，该战略应具备基础设施、从摇篮到坟墓的立法、主管监管机构以及经过培训的人员。
